Patent · US Active

Interleukin-1α antibodies

US8034337B2 · kind B2 · utility

1,007Cited by

14References

1Claims

0Family size

Assignee

XBIOTECH INC. · CA

Inventor

John Simard · Vancouver, CA

Key dates

Filing date	Jun 1, 2009
Grant date	Oct 11, 2011
Priority date	—
Expiry date	Jan 12, 2030

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/545
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Fully human monoclonal Abs includes (i) an antigen-binding variable region that exhibits very high binding affinity for IL-1α and (ii) a constant region that is effective at both activating the complement system though C1q binding and binding to several different Fc receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.